Pamidronate Disodium
Injection
| General Information: Pamidronate Disodium Injection is typically utilized in the treatment of moderate or severe hypercalcemia associated with malignancy, moderate to severe Paget's disease of the bone, and in the treatment of osteolytic bone metastases of breast cancer and osteolytic lesions of multiple myeloma. For indications, dosing and other information, please refer to the manufacture package insert.
|
| |
| Manufacturer |
Product |
Size |
NDC |
PI |
MSDS |
| American Regent |
Pamidronate |
3mg/mL, 10mL |
00517-0745-01 |
PI |
MSDS |
| |
|
9mg/mL, 10mL |
00517-0746-01 |
PI |
MSDS |
| Sagent |
Pamidronate Disodium |
3mg/mL, 10mL |
25021-0802-10 |
PI |
MSDS |
| |
|
9mg/mL, 10mL |
25021-0803-10 |
PI |
MSDS |
|
| |
| Clinical Data: For any questions or
for further information related to Pamidronate Disodium Injection, clinical pharmacology,
additional indications and usages, contraindications, warnings,
precautions, adverse reactions, dosage, administration and/or
storage of this product, please
contact BDI
Pharma or call
1-800-948-9834. |
| |
|
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |